Lincluden Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-19,007
Closed -$2.76M 77
2019
Q4
$2.76M Sell
19,007
-12,977
-41% -$1.79M 0.25% 52
2019
Q3
$4.26M Sell
31,984
-9,316
-23% -$1.2M 0.4% 41
2019
Q2
$4.72K Sell
41,300
-10,151
-20% -$1.19M 0.3% 37
2019
Q1
$6.38M Sell
51,451
-1,715
-3% -$195K 0.61% 27
2018
Q4
$5.35M Sell
53,166
-33,801
-39% -$3.8M 0.41% 29
2018
Q3
$11.1M Sell
86,967
-5,686
-6% -$676K 0.92% 22
2018
Q2
$10M Buy
92,653
+1,339
+1% +$146K 0.73% 31
2018
Q1
$9.67M Sell
91,314
-5,340
-6% -$620K 0.77% 27
2017
Q4
$11.3M Buy
96,654
+32,476
+51% +$3.67M 0.79% 28
2017
Q3
$7.3M Buy
64,178
+695
+1% +$80.2K 0.57% 37
2017
Q2
$7.91M Buy
63,483
+2,374
+4% +$281K 0.68% 32
2017
Q1
$7.25M Buy
61,109
+7,717
+14% +$875K 0.65% 34
2016
Q4
$6.74M Hold
53,392
0.73% 36
2016
Q3
$6.74M Buy
53,392
+329
+0.6% +$40.6K 0.99% 34
2016
Q2
$6.2M Buy
53,063
+446
+0.8% +$50.5K 1.03% 31
2016
Q1
$5.45M Buy
52,617
+763
+1% +$73.8K 0.92% 37
2015
Q4
$5.17M Sell
51,854
-582
-1% -$56.9K 1.05% 34
2015
Q3
$4.78M Sell
52,436
-52
-0.1% -$5.21K 0.92% 35
2015
Q2
$5.57K Sell
52,488
-1,720
-3% -$190K 0.69% 36
2015
Q1
$6.18M Sell
54,208
-19,710
-27% -$2.25M 0.88% 37
2014
Q4
$8.14M Sell
73,918
-3,456
-4% -$364K 0.8% 35
2014
Q3
$7.55M Buy
77,374
+83
+0.1% +$8.16K 0.73% 40
2014
Q2
$7.79M Buy
77,291
+5,423
+8% +$529K 0.71% 42
2014
Q1
$6.6M Buy
71,868
+1,328
+2% +$122K 0.62% 43
2013
Q4
$6.38M Buy
70,540
+3,214
+5% +$278K 0.58% 43
2013
Q3
$5.37M Sell
67,326
-3,471
-5% -$273K 0.67% 42
2013
Q2
$5.15K Buy
+70,797
New +$5.29M 0.01% 45

Other funds holding ZBH

Lincluden Management's ZBH Position: Q1 2020 in Review

Lincluden Management sold out of Zimmer Biomet (ZBH) in Q1 2020, closing a stake of 19,007 shares — an estimated $2.76M sold.

Lincluden Management first reported a position in ZBH in Q2 2013 and held it in 27 quarters. The position peaked at $11.3M in Q4 2017. 883 funds tracked by Wall St. Rank hold ZBH as of Q1 2020.

  • Lincluden Management reported no remaining Zimmer Biomet position as of Q1 2020 after selling out during the quarter.
  • Lincluden Management sold 19,007 Zimmer Biomet shares in Q1 2020, an estimated $2.76M.
  • Lincluden Management first reported a position in Zimmer Biomet in Q2 2013 and held it in 27 quarters.
  • Lincluden Management's Zimmer Biomet position peaked at $11.3M in Q4 2017.
  • 883 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2020.

Based on Lincluden Management's 13F filing for Q1 2020, filed 14 May 2020.